The Stallion India Fluorochemicals IPO (Initial Public Offering) is generating buzz among investors as it gears up for listing. Here’s an in-depth analysis of Stallion India IPO, its details, financials, and whether you should consider investing.
About the Company
Founded in 2002, Stallion India Fluorochemicals Limited is a leading player in the fluorochemicals sector, primarily engaged in the debulking, blending, and processing of refrigerants and industrial gases. These gases are used across industries such as semiconductors, automotive, pharmaceuticals, healthcare, fire safety, and electronics.
The company operates four strategically located plants in Maharashtra, Rajasthan, and Haryana, ensuring efficient distribution and cost advantages. Stallion India’s competitive strengths lie in its market reputation, diverse client base across growing industries, and a leadership team with decades of expertise. The company’s track record of consistent financial performance adds to its appeal for investors.
Stallion India IPO – Issue Details
| IPO Date | January 16, 2025 to January 20, 2025 |
| Listing Date | January 23, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹85 to ₹90 per share |
| Lot Size | 165 Shares |
| Total Issue Size | 2,21,61,396 shares (aggregating up to ₹199.45 Cr) |
| Fresh Issue | 1,78,58,740 shares (aggregating up to ₹ 160.73 Cr) |
| Offer for Sale | 43,02,656 shares of ₹10 (aggregating up to ₹38.72 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Minimum investment for retail investors starts at ₹14,850, with specific quotas reserved for QIBs, NIIs, and retail participants.
Financial Performance
Amount in ₹ Crore
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 235.69 | 203.14 | 126.18 | 98.01 |
| Revenue | 141.53 | 236.23 | 226.06 | 186.34 |
| Profit After Tax | 16.57 | 14.79 | 9.75 | 21.11 |
| Net Worth | 134.53 | 117.96 | 70.7 | 60.94 |
| Total Borrowing | 81.05 | 65.35 | 18.27 | 1.97 |
The company demonstrates steady revenue growth and improved profitability, reflecting operational efficiencies and strong demand for its products.
Stallion India IPO Size
The Size of the IPO is ₹ 199.45 Crores which contains :
- OFS – ₹ 38.72 Crores and
- Fresh Issue – ₹ 160.73
Objects of the IPO
The objects of the IPO contains both OFS and fresh issue.
a) OFS : Under Offer for sale (OFS), the funds goes to selling share holders.
b) Fresh issue: This would be used for the following.
- Funding incremental working capital requirements of the Company.
- Funding capital expenditure requirements for our Semi-conductor & Specialty Gas debulking & blending facility (“Khalapur, Maharashtra”).
- Funding capital expenditure requirements for our Refrigerant debulking & blending facility (“Mambattu, Andhra Pradesh”).
- General Corporate Purposes.
P/E Ratio and Peer Comparison
Based on the EPS for CY24 of ₹ 2.5, the P/E works out to be 36x. As per RHP, its peers like Gujarat Flurochemicals Is trading at 108x (Highest) and SRF Limited trading at 49x (Lowest) and industry composite is 57x. Hence the IPO price is attractively priced.
Reasons to Invest in Stallion India IPO
- Strong Market Recognition: Stallion India has established itself as a trusted supplier of fluorochemicals. Its brand reputation and customer relationships in industries like semiconductors and automotive ensure sustained demand.
- Diversified Product Portfolio: The company offers a broad range of refrigerants and industrial gases, catering to sectors with strong growth potential. This diversification reduces reliance on any single industry, ensuring steady revenue across market cycles.
- Expansion Plans : The IPO proceeds will fund expansions at its facilities in Maharashtra and Andhra Pradesh. These projects are expected to increase production capacity, meeting the rising demand for fluorochemicals.
- Favorable Industry Outlook: With increasing applications of fluorochemicals in electronics, pharmaceuticals, and fire safety, the demand for these products is expected to grow. Stallion India is well-positioned to capitalize on this trend.
- Consistent Financial Performance: The company has shown a consistent ability to grow revenue and improve profitability, supported by a strong balance sheet and efficient operations.
Risk Factors in this IPO
- Cyclicality of Demand : Stallion India’s end-user industries, such as automotive and semiconductors, are prone to demand fluctuations based on economic conditions. This cyclicality could affect revenue stability.
- Regulatory and Environmental Risks : The fluorochemicals industry is heavily regulated due to its environmental impact. Stricter environmental policies or compliance failures could pose operational challenges.
- High Competition : The industry is dominated by established players, both domestic and international. Competitive pricing and market share battles may pressure margins.
- Foreign Exchange Risk : With exposure to international markets, currency fluctuations could impact profitability.
- Debt-Equity Increase : While manageable, the rising debt-to-equity ratio indicates a growing reliance on borrowings, which might affect financial flexibility.
FAQs on Stallion India IPO
1) What is the GMP of Stallion India IPO?
The Stallion India IPO currently trades at a premium of ₹15-21 in the grey market, reflecting moderate investor interest. However, GMP trends should not be the sole deciding factor in investment decisions.
2) How to Apply / How to buy this IPO?
Investors can apply through:
- UPI-based ASBA Applications: Available via net banking or trading apps.
- Physical Applications: Through designated branches of syndicate members.
3) Is Stallion India IPO a good investment?
This IPO is available at attractive valuations. Investors should assess relevant strenghts and risk factors for investment.
Stallion India IPO – Invest or Avoid?
You might be wondering whether this IPO is good or bad for investment.
Stallion India IPO offers a mix of strong fundamentals, favorable valuation, and growth potential. While the company has several strengths, including its diversified portfolio and expansion plans, investors must weigh the risks, particularly regulatory challenges and competitive pressures.
High risk investors can consider such IPOs for investment from long term perspective after understanding all the risk factors indicated in the RHP.
Disclaimer: The above article is for educational purposes only and should not be considered as investment advice. Please consult a financial advisor before making any investment decisions.
- 20 Highest Return Mutual Funds Over the Last 20 Years - October 14, 2026
- 5 Best Value Mutual Funds for 2026 Based on Rolling Returns - October 11, 2026
- 10 Mutual Funds with Best Risk-Adjusted Returns to Invest in 2026 - October 10, 2026
2 comments
Add a comment ↓best post…….
Dear Suresh Garuji,
Thanks to consider request and restart the IPO analysis.